EDGAR Filing Documents for 0001193125-06-228211

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-06-228211

Filing Date

2006-11-08

Accepted

2006-11-08 15:05:33

Documents

Period of Report

2006-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	457965
2	CERTIFICATION PURSUANT TO RULE 13A-14(A) OF JOSEPH K. BELANOFF, M.D.	dex311.htm	EX-31.1	8428
3	CERTIFICATION PURSUANT TO RULE 13A-14(A) OF FRED KURLAND	dex312.htm	EX-31.2	8380
4	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 OF JOSEPH K. BELANOFF, M.D.	dex321.htm	EX-32.1	3484
5	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 OF FRED KURLAND	dex322.htm	EX-32.2	3400
	Complete submission text file	0001193125-06-228211.txt		482880

Mailing Address

Business Address 275 MIDDLEFIELD ROAD SUITE A MENLO PARK CA 94025

CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 061197100
SIC: 2834 Pharmaceutical Preparations